Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model
Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model
复制标题
DOI:
10.1016/j.plefa.2014.08.004
复制
发表时间:
2014-11-01
影响因子:
3
通讯作者:
Yoshikawa, K.
中科院分区:
文献类型:
--
作者:
Iwasa, K.;Yamamoto, S.;Yoshikawa, K.
Previously, we have demonstrated that prostamide/PGF synthase, which catalyzes the reduction of prostaglandin (PG) H-2 to PGF(2 alpha) is constitutively expressed in myelin sheaths and cultured oligodendrocytes, suggesting that PGF(2 alpha) has functional significance in myelin-forming oligodendrocytes. To investigate the effects of PGF(2 alpha)/FP receptor signaling on demyelination, we administrated FP receptor agonist and antagonist to cuprizone-exposed mice, a model of multiple sclerosis. Mice were fed a diet containing 0.2% cuprizone for 5 weeks, which induces severe demyelination, glial activation, proinflammatory cytokine expression, and motor dysfunction. Administration of the FP receptor antagonist AL-8810 attenuated cuprizone-induced demyelination, glial activation, and TNF alpha expression in the corpus callosum, and also improved the motor function. These data suggest that during cuprizone-induced demyelination, PGF(2 alpha)/FP receptor signaling contributes to glial activation, neuroinflammation, and demyelination, resulting in motor dysfunction. Thus, FP receptor inhibition may be a useful symptomatic treatment in multiple sclerosis. (C) 2014 Elsevier Ltd. All rights reserved.